REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Huakang Biomedical Holdings Company Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Huakang Biomedical Holdings Company Limited Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Huakang Biomedical Holdings Company Limited researches, develops, manufactures and sells IVD reagents. The company was founded in 2003 and is headquartered in Hong Kong.

Headquarters
3Rd Floor, Effectual Building, 16 Hennessy Road, Wanchai
Hong Kong; Hong Kong;

Contact Details: Purchase the Huakang Biomedical Holdings Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Huakang Biomedical Holdings Company Limited report to view the information.
Outstanding Shares:
Purchase the Huakang Biomedical Holdings Company Limited report to view the information.
Registered Capital:
Purchase the Huakang Biomedical Holdings Company Limited report to view the information.
Financial Auditors:
Purchase the Huakang Biomedical Holdings Company Limited report to view the information.
Incorporation Date:
2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
28.5%
Purchase this report to view the information.
24.1%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Huakang Biomedical Company Limited
100%
King Grace Company Limited
100%
Nutronic Biomedical Group Limited
100%
Company Performance
Financial values in the chart are available after Huakang Biomedical Holdings Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
3.95%▲
Total operating revenue
2.3%▲
Operating profit (EBIT)
-19.14%▼
EBITDA
N/A
Net Profit (Loss) for the Period
-22.27%▼
Total assets
4.14%▲
Total equity
3.2%▲
Operating Profit Margin (ROS)
-2.17%▼
Net Profit Margin
-2.24%▼
Return on Equity (ROE)
-0.49%▼
Debt to Equity Ratio
4.63%▲
Quick Ratio
0.28%▲
Cash Ratio
0.35%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo